Pattern of recurrence of early bc differs by intrinsic subtype & proliferation index

[Hopeful]

What I found interesting was this:

In addition, those other patients with Luminal-HER2 subtype could benefit from a second treatment with trastuzumab in order to decrease the second peak of recurrences.

I recall discussion here from way back, that perhaps triple positives could do with a "booster" of Herceptin at the 5 or 7 year mark.

Hopeful